NFAT5 and myeloid sarcoma: Finally, an overall and significant increase in NFAT5 gene expression levels was seen in all MS cases (* p < 0.05; Figure 5D), which was contributed by RRMS (p = 0.051; Figure 5D′) and SPMS (** p < 0.01; Figure 5D′), but not PPMS cases (p > 0.05; Figure 5D′).